Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|
EPS | ($0.1) | ($0.4) | ($1.8) | ($3.0) | ($2.0) | ($12.2) | ($15.8) | ($19.2) | ($15.2) | ($19.4) | ($8.5) |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, BeiGene, Ltd.'s last 12-month EPS is ($7.7), based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, BeiGene, Ltd.'s EPS growth was (16.6%). The average annual EPS growth rates for BeiGene, Ltd. have been (17.3%) over the past three years, (11.2%) over the past five years.
Over the last year, BeiGene, Ltd.'s EPS growth was (16.6%), which is lower than industry growth of (0.2%). It indicates that BeiGene, Ltd.'s EPS growth is Bad.